Clinical Trials Directory

Trials / Completed

CompletedNCT04383041

Study to Learn More About Outcomes Reported by Patients Suffering From Type 2 Diabetes Using a Digital Data Collection Tool

Digital Collected Patient Reported Outcomes in a Diabetes Cohort

Status
Completed
Phase
Study type
Observational
Enrollment
32 (actual)
Sponsor
Bayer · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this study researchers want to gain more information on patients who are treated with Metformin for their Type 2 Diabetes. Adult female and male patients with a prescription of a Metformin containing drug will be invited to the study in a public pharmacy after the decision for treatment with Metformin has been made by the treating physician. The pharmacist will provide interested participants access to a special phone App and participants are asked to complete via this phone App a questionnaire on their health situation with special focus on their Type 2 Diabetes. This includes questions on complications and self-care activities in relation to their diabetes, questions on quality of life and health history. There will be no extra visit to the treating doctor or a pharmacy. The study is aiming to have the questionnaire completed by 300 participants.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionCompleting questionnaires via ePRO app from their own mobile devices

Timeline

Start date
2020-07-02
Primary completion
2020-12-09
Completion
2021-01-27
First posted
2020-05-11
Last updated
2021-07-01

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04383041. Inclusion in this directory is not an endorsement.